ITCI
Assenagon Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-146,082
| Closed | -$12.2M | – | 1342 |
|
|
2024
Q4 | $12.2M | Sell |
146,082
-86,851
| -37% | -$7.25M | 0.02% | 444 |
|
|
2024
Q3 | $17M | Sell |
232,933
-109,910
| -32% | -$8.04M | 0.03% | 364 |
|
|
2024
Q2 | $23.5M | Sell |
342,843
-306,974
| -47% | -$21M | 0.05% | 247 |
|
|
2024
Q1 | $45M | Sell |
649,817
-114,157
| -15% | -$7.9M | 0.11% | 135 |
|
|
2023
Q4 | $54.7M | Buy |
763,974
+275,368
| +56% | +$19.7M | 0.15% | 108 |
|
|
2023
Q3 | $25.5M | Buy |
488,606
+298,303
| +157% | +$15.5M | 0.08% | 188 |
|
|
2023
Q2 | $12M | Buy |
190,303
+57,492
| +43% | +$3.64M | 0.04% | 301 |
|
|
2023
Q1 | $7.19M | Buy |
132,811
+52,583
| +66% | +$2.85M | 0.03% | 448 |
|
|
2022
Q4 | $4.25M | Buy |
80,228
+32,806
| +69% | +$1.74M | 0.02% | 539 |
|
|
2022
Q3 | $2.21M | Buy |
47,422
+8,232
| +21% | +$383K | 0.01% | 656 |
|
|
2022
Q2 | $2.24M | Sell |
39,190
-53,510
| -58% | -$3.05M | 0.01% | 772 |
|
|
2022
Q1 | $5.67M | Sell |
92,700
-35,411
| -28% | -$2.17M | 0.02% | 475 |
|
|
2021
Q4 | $6.71M | Buy |
+128,111
| New | +$6.71M | 0.02% | 407 |
|
|
2021
Q2 | – | Sell |
-208,301
| Closed | -$7.07M | – | 1395 |
|
|
2021
Q1 | $7.07M | Buy |
208,301
+4,313
| +2% | +$146K | 0.03% | 393 |
|
|
2020
Q4 | $6.49M | Sell |
203,988
-271,906
| -57% | -$8.65M | 0.03% | 283 |
|
|
2020
Q3 | $12.2M | Buy |
475,894
+209,143
| +78% | +$5.37M | 0.07% | 140 |
|
|
2020
Q2 | $6.85M | Buy |
266,751
+120,612
| +83% | +$3.1M | 0.04% | 235 |
|
|
2020
Q1 | $2.25M | Buy |
146,139
+127,194
| +671% | +$1.95M | 0.02% | 307 |
|
|
2019
Q4 | $650K | Buy |
+18,945
| New | +$650K | ﹤0.01% | 587 |
|